SAQ 1646 – Posterior epistaxis on rivaroxaban

Marked out of 12.00

A 64-year-old man presents to the ED with epistaxis. He takes rivaroxaban for atrial fibrillation stroke prevention. Assessment suggests large-volume ongoing posterior epistaxis.

List four history features that will influence management and explain the relevance of each.

(Marked out of 4.0)


/ 4

State two treatment options for reversal of rivaroxaban-associated coagulopathy.

(Marked out of 2.0)


/ 2

List three treatments aimed at stopping the ongoing haemorrhage, and state the clinical indication for each.

(Marked out of 6.0)


/ 6

Total Score: 0 / 12

Percentage: 0%